One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™

General Information

Summary The purpose of this trial is to evaluate the long-term safety in subjects previously implanted with VC-01™ combination product.
Clinical trials phase Long term follow up
Start date (estimated) 2016-11-07
End date (estimated) 2023-11-30
Clinical feature
Label Diabetes Mellitus, Type 1

Administrative Information

Other study identifiers
Name VC01-201
Regulatory body approval
Public contact
Sponsors ViaCyte

Cell Line

Stem cell lines obtained from


Recruitment Status Enrolling by invitation
Estimated number of participants 200